MOMA Therapeutics

company

About

MOMA Therapeutics operates as a biotechnology company.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$150M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
51 - 100
Operating Status
Active

MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$150M
MOMA Therapeutics has raised a total of $150M in funding over 2 rounds. Their latest funding was raised on May 10, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 10, 2022 Series B $150M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
MOMA Therapeutics is funded by 1 investors. Pavilion Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Pavilion Capital Series B